| Product Code: ETC7659615 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Polymyalgia Rheumatica Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Polymyalgia Rheumatica Treatment Market - Industry Life Cycle |
3.4 Israel Polymyalgia Rheumatica Treatment Market - Porter's Five Forces |
3.5 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Polymyalgia Rheumatica Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of polymyalgia rheumatica in Israel |
4.2.2 Growing awareness about the disease and available treatment options |
4.2.3 Advancements in medical research leading to new and improved treatment methods |
4.3 Market Restraints |
4.3.1 High cost associated with polymyalgia rheumatica treatment |
4.3.2 Limited availability of specialized healthcare professionals for treating the disease |
4.3.3 Stringent regulatory requirements for approval of new treatment options |
5 Israel Polymyalgia Rheumatica Treatment Market Trends |
6 Israel Polymyalgia Rheumatica Treatment Market, By Types |
6.1 Israel Polymyalgia Rheumatica Treatment Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.4 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Disease-Modifying Anti-Rheumatic Drugs (DMARDS), 2021- 2031F |
6.1.5 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), 2021- 2031F |
6.1.6 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Polymyalgia Rheumatica Treatment Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Polymyalgia Rheumatica Treatment Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Polymyalgia Rheumatica Treatment Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.4.5 Israel Polymyalgia Rheumatica Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Polymyalgia Rheumatica Treatment Market Import-Export Trade Statistics |
7.1 Israel Polymyalgia Rheumatica Treatment Market Export to Major Countries |
7.2 Israel Polymyalgia Rheumatica Treatment Market Imports from Major Countries |
8 Israel Polymyalgia Rheumatica Treatment Market Key Performance Indicators |
8.1 Average time to diagnosis of polymyalgia rheumatica patients |
8.2 Patient adherence rates to prescribed treatment regimens |
8.3 Number of clinical trials conducted for developing new treatment approaches |
9 Israel Polymyalgia Rheumatica Treatment Market - Opportunity Assessment |
9.1 Israel Polymyalgia Rheumatica Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Polymyalgia Rheumatica Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Israel Polymyalgia Rheumatica Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Israel Polymyalgia Rheumatica Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Polymyalgia Rheumatica Treatment Market - Competitive Landscape |
10.1 Israel Polymyalgia Rheumatica Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Polymyalgia Rheumatica Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here